Session

Back to Programme Overview

Penile cancer - important details on surgical approaches

Poster Session 53

  • Location:
    Room Berlin, North Hall (Level 1)
  • Chairs:
     O. Hakenberg, Rostock (DE)
     S. Horenblas, Amsterdam (NL)
     V. Sangar, Manchester (GB)
  • Aims and objectives of this session

    This session will update organ-sparing surgery in penile cancer from large series. In addition, guideline adherance and quality of care issues will be discussed.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
706
The adherence to the EAU Guidelines on penile cancer treatment could influence the survival: Multicenter, retrospective study

By: Cindolo L.1, Bada M.1, Nyirády P.2, Varga J.2, Ditonno P.3, Boccasile S.3, Battaglia M.3, Chiodini P.4, Berardinelli F.1, De Nunzio C.5, Tema G.5, Veccia A.6, Antonelli A.6, Simeone C.6, Puliatti S.7, Micali S.7, Schips L.1

Institutes: 1ASL Abruzzo 2, Dept. of Urology, Chieti, Italy, 2Budapest Hospital, Dept. of Urology, Budapest, Hungary, 3University of Bari, Dept. of Emergency and Organ Transplantation, Bari, Italy, 4Second University of Naples, Medical Statistics Unit, Naples, Italy, 5S. Andrea Hospital, Dept. of Urology, Rome, Italy, 6Spedali Civili, Dept. of Urology, Brescia, Italy, 7University of Modena and Reggio Emilia, Dept. of Urology, Baggiovara, Italy

707
Is the incidence of penile carcinoma in situ increasing in England and the rest of Europe?

By: Rodney S.1, Arya M.2, Muneer A.3

Institutes: 1University College London, Dept. of Interventional Science, London, United Kingdom, 2University College London Hospital, Dept. of Urology, London, United Kingdom, 3University College London Hospital, Dept. of Urology, London, United Kingdom

708
The genomic profiling of penile carcinoma: DNA copy number aberrations and validation of candidate driver genes

By: La Touche S.1, Lemetre C.2, Lambros M.3, Stankiewicz E.1, Ng C.2, Weigelt B.2, Rajab R.4, Tinwell B.4, Corbishley C.4, Watkin N.5, Berney D.1, Reis-Filho J.2

Institutes: 1Barts Cancer Institute, Dept. of Molecular Oncology, London, United Kingdom, 2Memorial Sloan Kettering Cancer Centre, Dept. of Pathology, New York, United States of America, 3Institute of Cancer Research, Dept. of Molecular Pathology, London, United Kingdom, 4St Georges Hospital, Dept. of Pathology, London, United Kingdom, 5St Georges Hospital, Dept. of Urology, London, United Kingdom

709
PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in evolving disease states of penile cancer

By: Adimonye A.1, Stankiewicz E.1, Nicholson S.2, Hall E.3, Kudahetti S.1, Rajab R.4, Corbishley C.4, Lu Y-J.1, Bahl A.5, Watkin N.6, Berney D.1

Institutes: 1Barts Cancer Institute, Centre for Molecular Oncology, London, United Kingdom, 2Imperial College Healthcare NHS Trust, Dept. of Medical Oncology, London, United Kingdom, 3The Institute of Cancer Research, Clinical Trials & Statistics Unit, London, United Kingdom, 4St George’s Hospital, Dept. of Histopathology, London, United Kingdom, 5Bristol Haematology and Oncology Centre, Dept. of Clinical Oncology, Bristol, United Kingdom, 6St George’s Hospital, Dept. of Urology, London, United Kingdom

710
A critical comparative analysis of operative complication and oncological outcome between robot assisted video endoscopic inguinal lymph node dissection and open inguinal lymph node dissection

By: Singh A., Shah S., Bansal P., Chatterjee S., Rawal S.

Institutes: Rajiv Gandhi Cancer Hospital & Research Center, Dept. of Urology, Delhi, India

711
Thulium laser treatment of early stage penile cancer: Initial results and functional outcomes

By: Musi G., Conti A., Russo A., Mistretta F.A., Serino A., Tringali V., Catellani M., Cozzi G., Bianchi R., Delor M., Ferro M., Matei V., De Cobelli O.

Institutes: European Institute of Oncology, Dept. of Urology, Milan, Italy

712
Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma

By: Albersen M.1, Parnham A.2, Sahdev V.2, Christodoulidou M.2, Nigam R.2, Freeman A.2, Jameson C.2, Minhas S.2, Ralph D.2, Malone P.2, Muneer A.2

Institutes: 1UZ Leuven, Dept. of Urology, Leuven, Belgium, 2University College London Hospitals, Dept. of Urology, London, United Kingdom

713
The significance of close surgical margins in organ sparing surgery for penile squamous cell cancer

By: Sri D., Sujenthiran A., Lam W., Corbishley C., Yap T., Sharma D., Ayres B., Watkin N.

Institutes: St Georges Hospital, Dept. of Urology, London, United Kingdom

714
Prediction of postoperative complications after inguinal lymphadenectomy for penile cancer using a novel classification tool

By: Zhu Y.1, Gu W-J.1, Spiess P.2, Ye D-W.1

Institutes: 1Fudan University Shanghai Cancer Center, Dept. of Urology, Shanghai, China, 2H. Lee Moffitt Cancer Center, Dept. of Urology, Tampa, United States of America

715
Is sarcopenia a useful prognostic indicator in patients with squamous cell carcinoma of the penis?

By: Christodoulidou M.1, Attipa C.2, Burden S.3, Ramachandran N.4, Gibson D.3, Mitra A.5, Lal S.6, Nigam R.7, Malone P.7, Richards T.8, Muneer A.7

Institutes: 1University College Hospitals London, Dept. of Urology, London, United Kingdom, 2University College London, London, United Kingdom, 3University of Manchester, Dept. of Dietetics, London, United Kingdom, 4University College London Hospital, Dept. of Radiology, London, United Kingdom, 5University College London Hospital, Dept. of Oncology, London, United Kingdom, 6University of Manchester, Dept. of Gastroenterology, London, United Kingdom, 7University College London Hospital, Dept. of Urology, London, United Kingdom, 8University College London, Division of Surgery and Interventional Radiology, London, United Kingdom

716
Histopathologic and prognostic correlations regarding human papillomavirus (HPV) infection in penile squamous cell carcinomas (SCC) considering the novel 2016 WHO classification

By: Hölters S.1, Khalmurzaev O.2, Ueberdiek S.1, Loertzer P.1, Pfuhl T.3, Pryalukhin A.4, Hartmann A.5, Janssen M.1, Loertzer H.6, Wunderlich H.7, Hauschild E.8, Bohle R.M.4, Smola S.3, Stöckle M.1, Matveev V.2, Junker K.1

Institutes: 1Saarland University, Dept. of Urology and Paediatric Urology, Homburg, Germany, 2N.N. Blokhin Cancer Research Center, Dept. of Urology, Moscow, Russia, 3Saarland University, Institute of Virology, Homburg, Germany, 4Saarland University, Institute of Pathology, Homburg, Germany, 5Erlangen University, Institute of Pathology, Erlangen, Germany, 6Westpfalz-Klinikum GmbH, Dept. of Urology, Kaiserslautern, Germany, 7St Georg Klinikum, Dept. of Urology and Paediatric Urology, Blankenhein, Germany, 8Helios Clinics, Dept. of Urology, Blankenhein, Germany

717
Does residual penile intraepithelial neoplasia (PeIN) require adjuvant chemotherapy after surgical excision?

By: Ziada M., Parnham A., Christodoulidou M., Freeman A., Bunker C., Muneer A.

Institutes: University College London Hospital, Dept. of Urology, London, United Kingdom

718
Dacomitinib (Daco) induction therapy for locally-advanced (LA) or metastatic penile squamous cell carcinoma (PSCC): An open label, single-arm, phase 2 study

By: Necchi A.1, Lo Vullo S.2, Raggi D.1, Giannatempo P.1, Nicolai N.3, Piva L.3, Biasoni D.3, Catanzaro M.3, Torelli T.3, Stagni S.3, Calareso G.4, Togliardi E.5, Colecchia M.4, Busico A.4, Perrone F.4, Gloghini A.4, Sonpavde G.6, Mariani L.7, Salvioni R.8

Institutes: 1Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2Fondazione IRCCS – Istituto Nazionale Dei Tumori, Clinical Epidemiology and Trials Organization Unit, Milan, Italy, 3Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Urology, Milan, Italy, 4Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Radiology, Milan, Italy, 5Fondazione IRCCS – Istituto Nazionale Dei Tumori, Pharmacy Unit, Milan, Italy, 6UAB Comprehensive Cancer Center, Medical Oncology & Hematology, Birmingham, United States of America, 7Fondazione IRCCS Istituto Nazionale Dei Tumori, Clinical Epidemiology and Trials Organization Unit, Milan, Italy, 8Fondazione IRCCS Istituto Nazionale Dei Tumori, Dept. of Urology, Milan, Italy

V90
Saphenous-sparing laparoscopic inguinal lymphadenectomy

By: Chiapparrone G.1, Rapisarda S.2, De Concilio B.3, Zeccolini G.3, Trombetta C.1, Celia A.3

Institutes: 1University of Trieste, Dept. of Urology, Trieste, Italy, 2University of Catania, Dept. of Urology, Catania, Italy, 3San Bassiano Hospital, Dept. of Urology, Bassano del Grappa, Italy